Skip to main content
. 2017 Jun 30;14(3):3421–3428. doi: 10.3892/ol.2017.6503

Table V.

The frequency of LAPTM4B in male papillary thyroid carcinoma patients and male healthy controls.

LAPTM4B status Healthy controls, n (%) n=448 PTC, n (%) n=51 OR (95% CI) P-value
Allele
  *1 663 (74.0) 76 (74.5)
  *2 233 (26.0) 26 (25.5) 0.996 (0.615–1.612) 0.986a
Genotype
  *1/1 241 (53.8) 26 (50.9)
  *1/2 181 (40.4) 24 (47.1) 1.187 (0.649–2.169) 0.577b
  *2/2 26 (5.8) 1 (2.0) 0.445 (0.057–3.481) 0.440b
a

Compared with LAPTM4B*1.

b

Compared with LAPTM4B*1/1. LAPTM4B, lysosome-associated protein transmembrane 4-β; PTC, papillary thyroid carcinoma; CI, confidence interval.